(2024 On-Demand) Use of Biosimilars in Inflammatory and Immunological Diseases

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Define biosimilars in inflammatory diseases.
• Describe issues of concern in the use of biosimilars in clinical practice.
• Summarize team strategies for improving care coordination and communication to advance the use of biosimilars in treating patients with inflammatory diseases.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Brinda Joshi, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.